New Key Statistics Module, Z-Score and F-Score
NAS:DNLI Key Ratios
| Market Cap $ M | 2,611.17 |
| Enterprise Value $ M | 1,724.85 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.79 |
| Price/Sales | 8.74 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 295.00 |
| EPS (TTM) $ | -0.96 |
| Beneish M-Score | 13.8 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -8.29 |
| EV-to-EBITDA | -8.65 |
| PEG | -- |
| Shares Outstanding M | 142.61 |
| Net Margin (%) | -46.46 |
| Operating Margin % | -70.46 |
| Pre-tax Margin (%) | -46.45 |
| Quick Ratio | 11.79 |
| Current Ratio | 11.79 |
| ROA % (ttm) | -10.26 |
| ROE % (ttm) | -11.92 |
| ROIC % (ttm) | -76.60 |
| Dividend Yield % | -- |
| Altman Z-Score | 11.97 |
DNLI Number of Guru Trades
DNLI Volume of Guru Trades
Gurus Latest Trades with NAS:DNLI
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:DNLI is held by these investors
Total 4
Denali Therapeutics Inc Insider Transactions
No Available Data
News about NAS:DNLI
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers